Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Marta Palau Requena

Marta Palau Requena

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Marta Palau Requena

Marta Palau Requena

Marta Palau Requena

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Related news

Dr. Mar Mañú in the European Parliament

Dr. Mar Mañú, president of the coordinators of the 24 European Reference Network

The Scientific Coordinator of ERN-EuroBloodNet will lead for one year the group that defines the common strategy of the European Reference Networks to improve care for rare and complex diseases.

Membres de la xarxa ReALLNet

A European network facilitates access to precision medicine and clinical trials

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

Equip del projecte PHOENIX

We lead a project to test a more effective and less toxic drug against childhood cancer

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

See more

Related professionals

Ángeles Mesas Idáñez

Ángeles Mesas Idáñez

Clinical Pharmacology
Read more
Nerea Rayo Garcia

Nerea Rayo Garcia

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Irene Perona Gómez

Irene Perona Gómez

Research technician
Epidemiology and Public Health
Read more
David Téllez Velasco

David Téllez Velasco

Research technician
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.